Abstract
Background: The ingestion of polyunsaturated fatty acids is vital for brain health, supporting cognitive development and helping to prevent chronic diseases, including neurodegenerative processes. Objective: This study aimed to investigate the effects of corn oil on the biochemical and neurochemical parameters of Drosophila melanogaster expressing human amyloid precursor protein β42 (APP-β42). Methods: The flies were fed a diet supplemented with 37.8 mg/mL of corn oil from the larval stage until adulthood. Results: A diet supplemented with corn oil induced significant changes in biochemical markers, such as a decrease in head cholesterol levels (p < 0.001); decreased catalase activity and hydrogen peroxide levels in the heads (p < 0.0001) and thoracic muscles (p < 0.0001); reduced glutathione levels in the heads (p < 0.0001) and muscles (p < 0.01); and reduced formazan production (p < 0.01) and citrate synthase (CS) activity (p < 0.0001) in the head. However, in thoracic muscle, ingestion of corn oil led to an increase in formazan production (p < 0.01) and no significant change in CS activity. Lactate levels decreased in the heads (p < 0.0001) and thoraces (p < 0.001) after flies were fed corn oil. Finally, ingestion of corn oil resulted in a significant rise in acetylcholinesterase activity in the heads (p < 0.001) and thoracic muscles (p < 0.01). Conclusions: These results suggest that consuming corn oil reduces the oxidative stress typical of an Alzheimer’s disease model by enhancing antioxidant defenses.
Keywords: Drosophila melanogaster, functional food, biochemical and neurochemical markers, Alzheimer’s disease
1. Introduction
Alzheimer’s disease (AD) is the primary cause of dementia worldwide, characterized by memory loss, language difficulties, impaired spatial orientation, and other significant cognitive declines, leading to decreased independence and quality of life [1]. Several hypotheses aim to explain its underlying mechanisms. One prominent theory is the amyloid cascade hypothesis, which involves the extracellular buildup of β-amyloid peptide plaques (Aβ) through APP metabolism [2]. Another is the tau hyperphosphorylation hypothesis, where neurofibrillary tangles composed of hyperphosphorylated tau protein are observed [3]. Additionally, evidence shows that chronic inflammation, oxidative stress, and metabolic alterations also significantly contribute to disease progression [4].
Diagnosis is typically confirmed through testing, followed by the initiation of treatment [5]. Currently, treatments mainly provide symptomatic relief, aiming to reduce cognitive and behavioral symptoms rather than halt the progression of the disease. Common medications include acetylcholinesterase inhibitors such as donepezil, rivastigmine, and galantamine. Memantine, an N-methyl-D-aspartate (NMDA) receptor antagonist, is also used [6]. Although new therapies are approved annually in various countries, their actual effectiveness remains a matter of debate, as these drugs do not stop long-term disease progression and can cause side effects [7].
The primary existing drugs for AD are acetylcholinesterase inhibitors, which work by preventing the degradation of acetylcholine and supporting cholinergic transmission [8]. Based on the inflammatory aspect of AD, steroidal and non-steroidal anti-inflammatory drugs have also been explored as treatment options. However, they generally do not show satisfactory results and are associated with hepatotoxicity [9]. Additionally, monoclonal antibodies are believed to activate microglia to perform phagocytosis, which could prevent the formation of new amyloid plaques and slow disease progression [10].
Although these drugs help slow disease progression, they all have side effects. Acetylcholinesterase inhibitors often cause gastrointestinal issues such as nausea, vomiting, and diarrhea, as well as cardiac side effects [11]. Conversely, newer monoclonal antibodies carry a significant risk of amyloid-related imaging abnormalities (ARIAs), which may manifest as cerebral edema or microhemorrhages and require careful monitoring [12].
Studies indicate that non-pharmacological approaches using functional foods significantly aid in managing chronic diseases, such as neurodegenerative conditions [13,14]. These foods are abundant in bioactive substances such as omega-3 fatty acids, probiotics, prebiotics, postbiotics, polyphenols, flavonoids, carotenes, lycopene, folic acid, inositol, glycolipids, phytosterols, phosphatidylcholine, oleic acid, and specific antimicrobial peptides that can enhance metabolic health [14].
Corn oil is a vegetable oil widely used in the diet; its composition is rich in polyunsaturated fatty acids, especially linoleic acid (omega-6) and oleic acid (omega-9). When incorporated into the usual diet in moderation, it helps improve the plasma lipid profile, thereby reducing cholesterol [15]. Other components of corn oil, such as tocopherols and phytosterols, may contribute to antioxidant activity, protecting lipid membranes against oxidative peroxidation [16]. In this study, we aimed to investigate the effects of corn oil ingestion on biochemical and neurochemical markers in Drosophila melanogaster expressing APP-β42.
2. Materials and Methods
2.1. Fly Strain and Rearing
All experiments in this study used mutant fly lines sourced from the Bloomington Drosophila Stock Center (BDSC). The flies were maintained at 25 ± 1 °C on a standard diet composed of cornmeal (6.5% m/v), agar (CAS no. 9002-18-00) (1.0% m/v), yeast (6.5%), and Nipagin (CAS no. 99-76-3) (3.0% v/v) [17,18] or supplemented with corn oil (Bunge Ltd.a, Guaíra, Brazil) [13]. A standard diet composed of cornmeal (75% carbohydrates, 6.2% protein, and 1.5% lipids) and yeast (42% carbohydrates, 42% protein, and 6% lipids) represents 47.9 kcal. Additionally, a standard diet supplemented with corn oil (92% lipids) provides 48.61 kcal to the flies [19].
2.1.1. Phenotypic Expression
The line expressing amyloid precursor protein–β-amyloid peptide 42 (APP-β42) was cultured at 29 ± 1 °C and was created by recombining the APP-β42 transgene under the control of the upstream activation sequence (UAS)-APP-β42 with the glass multimer reporter Gal4 driver (GMR-Gal4) (BDSC 1104) on chromosome II, followed by crossing those flies with flies carrying UAS-APP-β42 (BDSC 33773) on chromosome II (Figure S1).
2.1.2. Exposure to a Diet Supplemented with Corn Oil
Both male and female flies were maintained under the experimental dietary conditions; however, only females were used for biochemical analyses because of their greater metabolic sensitivity to dietary changes. Males were maintained together with females during the adult exposure period to support normal feeding behavior. For the dietary treatment, adult mutant (GMR-Gal4; UAS-APP-β42) flies were allowed to oviposit for 3 h directly on either (1) a standard diet or (2) a standard diet supplemented with corn oil at a final concentration of 37.8 mg/mL, based on the experimental conditions previously established in our published study [19]. After the oviposition period, the parental flies were removed, and the offspring developed under their respective experimental conditions. Following adult eclosion, the flies continued to receive the corresponding standard or corn oil-supplemented diet for an additional 5 days.
At 5 days post-eclosion, female flies were collected, and their heads and thoraces were dissected separately for subsequent biochemical analyses. For each experimental group, three independent biological replicates were prepared. Each biological replicate consisted of 100 female flies, with heads and thoraces pooled separately, resulting in one pool of 100 heads and one pool of 100 thoraces per biological replicate.
The pooled tissues were homogenized with tungsten carbide beads (cat. no. 69997, Qiagen) in a 0.9% NaCl solution (pH 7.0; CAS no. 7647-14-5) containing a protease inhibitor cocktail diluted 1:200 (CAS no. 66701-25-5). Homogenates were centrifuged at 10,000× g for 10 min at 4 °C. The supernatants were collected and stored at −20 °C until analysis.
2.2. Smurf Test
Flies aged 14 days were subjected to starvation for 2 h and were subsequently exposed for 4 h to a diet containing sucrose (CAS no. 57-50-1) (5.0% m/v), agar (1.0% m/v), and brilliant blue (CAS no. 3844-45-9) (2.5% m/v) [20]. Then, the flies were anesthetized with FlyNap, and the dye ingestion was recorded through images (Figure S2).
Total Cholesterol
Homogenates of mutant D. melanogaster heads and thoraces were used to determine cholesterol levels using a kit (Bioclin, Brazil, cat. no. #K083).
2.3. Reduced Glutathione (GSH) Levels
Heads and thoraces of mutant flies were homogenized in a 100 mM sodium phosphate buffer (pH 7.4) with 6 mM EDTA (CAS no. 60-00-4) and 1 mg/mL OPT (CAS no. 643-79-8) for 15 min [21]. Glutathione levels were then measured spectrophotometrically at 420 nm using a Varian Cary 50MPR spectrophotometer (Varian Ltd., Melbourne, Australia).
Lactate Content
Lactate levels were determined using the lactate oxidase method following the manufacturer’s instructions (Labtest, Brazil, cat. no. 138-1/50). Absorbance was measured spectrophotometrically at 550 nm [22] using a Varian Cary 50MPR spectrophotometer (Varian Ltd., Melbourne, Australia). The lactate concentration was reported in mg/dL, normalized to the total protein content in the sample.
2.4. Catalase (CAT) Activity
Head and thorax homogenate samples were added to a quartz cuvette with a 50 mM potassium phosphate buffer (pH 7.0) as described by Aebi (1984) [23]. The reaction was started by adding 0.3 M hydrogen peroxide (H2O2), and absorbance was measured at 240 nm using a Varian Cary 50MPR spectrophotometer (Varian Ltd., Melbourne, Australia). Enzyme activity was determined using the molar extinction coefficient of H2O2 and expressed as mU/min/mg of protein.
Hydrogen Peroxide (H2O2) Production
Ferrous oxidation with xylenol orange (FOX) involves using a solution containing 0.1 mM xylenol orange (CAS no. 3618-43-7), 0.25 mM ferrous ammonium sulfate (CAS no. 7783-85-9), and 100 mM sorbitol (CAS no. 50-70-4). A 10 μL sample was combined with 190 μL of FOX reagent, mixed thoroughly, and incubated at room temperature for at least 30 min [24]. The resulting reaction’s optical density was then measured at 560 nm with a Varian Cary 50MPR spectrophotometer (Cary 50MPR, Varian Ltd., Melbourne, Australia).
2.5. Citrate Synthase (CS) Activity
Citrate synthase activity was initiated by adding 0.01 mg of protein to approximately 170 μL of Tris (200 mM, pH 8.0) buffer containing Triton X-100 (CAS no. 9036-19-5) 0.2% (v/v), 10 mM acetyl-CoA (CAS no. 32140-51-5), 1 mM 5’5’-dithiobis-2-nitrobenzoic acid (DTNB) (CAS no. 69-78-3), and 10 mM oxaloacetate (CAS no. 328-42-7) [25]. The CoA-SH produced by CS reduces DTNB to TNB, a reaction that can be monitored. CS activity was assessed by measuring the rate of TNB formation spectrophotometrically at 412 nm, following Srere (1969) [26], using a Varian Cary 50MPR spectrophotometer (Varian Ltd., Melbourne, Australia).
Formazan Production
Formazan production was analyzed using 30 μL of MTT (1.25 mM; CAS no. 298-93-1), 20 μL of pyrogallol (10 mM; CAS no. 87-66-1), and 10 μL of sample homogenized in a 50 mM phosphate buffer at pH 7.4. After 30 min of incubation at 27 °C, the formation rate of formazan was measured spectrophotometrically at 570 nm [27] with a Varian Cary 50MPR spectrophotometer (Varian Ltd., Melbourne, Australia). Each sample was tested in triplicate, and the absorbance values were normalized to the total protein amount in the sample.
2.6. Acetylcholinesterase (AChE) Activity
Homogenates of heads and thoraces (0.01 mg protein) were incubated in a solution containing 100 mM sodium phosphate buffer (pH 7.4) with 150 mM acetylthiocholine (CAS no. 1866-15-5) and 1 mM DTNB. AChE activity was determined spectrophotometrically at 412 nm using a Varian Cary 50MPR spectrophotometer (Varian Ltd., Melbourne, Australia). The activity was expressed as nanomoles of conjugate formed per minute per milligram of protein [28,29].
Protein Quantification
Protein concentration was measured using the Bradford method according to the manufacturer’s instructions (Labtest, Brazil, cat. no. 99-250). The assay measures the interaction between the protein and the reagent, with absorbance readings taken at 545 nm [30].
2.7. Statistical Analysis
Data are shown as the mean ± SEM, with N indicating the number of female flies per group in each experiment. Statistical analyses were conducted using GraphPad Prism version 8.0 software (San Diego, CA, USA). To evaluate the significance of differences between groups, t-tests with Bonferroni’s post hoc tests were used for untreated and treated flies. Differences were considered significant at p < 0.05.
3. Results
3.1. Cholesterol Levels
Flies expressing human APP and β42 fragments were fed a standard diet, leading to a significant increase in head cholesterol levels (p < 0.001) (Figure 1A). In contrast, there were no notable differences in cholesterol levels in the thorax (Figure 1B).
Figure 1.

Cholesterol levels in D. melanogaster, showing (A) head and (B) thorax from female APP-β42-expressing flies fed either a standard diet or a corn oil-supplemented diet. Data represent three independent biological replicates (n = 3), each consisting of pooled tissues from 100 females. The values represent the mean ± SEM (unpaired t-test) of three experiments. Differences were statistically significant at **** p < 0.0001, and ‘ns’ indicating p > 0.05.
3.1.1. Catalase Activity and Hydrogen Peroxide Production
Ingestion of corn oil significantly decreased catalase activity in the heads (p < 0.0001) (Figure 2A) and thoracic muscles (p < 0.0001) (Figure 2B). Additionally, hydrogen peroxide (H2O2) levels were reduced in the heads (p < 0.0001) (Figure 2C) and thoraces (p < 0.0001) (Figure 2D) of these flies.
Figure 2.

Catalase activity and H2O2 production in (A,C) heads (n = 3) and (B,D) thoraces (n = 3) of D. melanogaster fed a diet supplemented with corn oil. The values represent the mean ± SEM (unpaired t-test) of three experiments. The results were statistically significant at **** p < 0.0001.
3.1.2. Reduced Glutathione Levels
Mutant flies fed corn oil exhibited decreased levels of reduced glutathione in their heads (p < 0.0001) (Figure 3A) and muscles (p < 0.01) (Figure 3B).
Figure 3.

GSH concentration in (A) heads (n = 3) and (B) thoraces (n = 3) of Drosophila melanogaster fed a diet supplemented with corn oil. The values represent the mean ± SEM (unpaired t-test) of three experiments. The results were statistically significant at ** p < 0.01 and **** p < 0.0001.
3.2. Formazan Generation and Citrate Synthase (CS) Activity
Mutant flies fed corn oil exhibited a decrease in formazan production (p < 0.01) (Figure 4A) in the head and a higher concentration in the thoracic muscle (p < 0.01) (Figure 4B). The CS activity increased (p < 0.01) in the heads of flies fed corn oil (Figure 5A). However, in the thoracic muscle, ingestion of corn oil showed no significant change in CS activity (Figure 5B).
Figure 4.

Formazan production in the (A) heads (n = 3) and (B) thoraces (n = 3) of flies fed a standard diet or a diet supplemented with corn oil. The values represent the mean ± SEM (unpaired t-test) of three experiments. The results were statistically significant at * p < 0.05 and ** p < 0.01.
Figure 5.

CS activity in the (A) head (n = 3) and (B) thorax (n = 3) of D. melanogaster. The values represent the mean ± SEM (unpaired t-test) of three experiments. The results were statistically significant at ** p < 0.01; ‘ns’ indicating p > 0.05.
Lactate Levels
Lactate levels decreased in the heads (Figure 6A) (p < 0.0001) and thoraces (Figure 6B) (p < 0.001) after flies were fed corn oil for 5 days.
Figure 6.

Lactate concentration in the (A) heads (n = 3) and (B) thoraces (n = 3) of flies fed a diet supplemented with corn oil. The values represent the mean ± SEM (unpaired t-test) of three experiments. The results were considered statistically significant at **** p < 0.0001.
3.3. Acetylcholinesterase (AChE) Activity
Ingestion of corn oil resulted in a significant rise in acetylcholinesterase (AChE) activity in the heads (p < 0.01) (Figure 7A) and thoracic muscles (p < 0.0001) (Figure 7B).
Figure 7.

AChE activity in the (A) heads (n = 3) and (B) thoraces (n = 3) of mutant Drosophila melanogaster fed a diet supplemented with corn oil. The values represent the mean ± SEM (unpaired t-test) of three experiments. The results were statistically significant at ** p < 0.01 and **** p < 0.0001.
4. Discussion
Polyunsaturated fatty acids (PUFAs) are essential nutrients that must be obtained through diet because the human body cannot synthesize them [31]. They play important roles in maintaining cell membrane structure, regulating blood pressure and blood clotting, supporting immune function, facilitating the absorption of fat-soluble vitamins, and modulating inflammatory processes [31]. PUFAs have also been associated with improved cardiovascular health [32,33], cognitive and neuroprotective effects [34], and anti-inflammatory properties [35].
Corn oil is rich in linoleic acid (LA), an essential omega-6 PUFA that contributes to normal growth and development [36]. Previous studies have shown that LA can influence several cellular processes, including oxidative stress, inflammation, mitochondrial function, and endoplasmic reticulum stress, which may contribute to organ dysfunction under specific experimental conditions [36,37]. However, despite LA being essential for health, a higher intake can lead to the formation of oxidized linoleic acid metabolites (OXLAMs). OXLAMs can cause mitochondrial damage and have been associated with several diseases like Alzheimer’s and cancer [38].
The consumption of unsaturated fatty acids can directly affect the fatty acid profile of Drosophila melanogaster tissues, modify phospholipid composition, and thereby influence cell membrane fluidity and function [39]. Hunter-Manseau and colleagues (2024) [40], in their study on Drosophila melanogaster, demonstrated that the consumption of a high-fat diet without a prior fasting period resulted in decreased CS activity and complex IV, consequently causing mitochondrial impairment by drastically reducing the respiration rate.
Nevertheless, it is important to emphasize that the present study evaluated supplementation with whole corn oil rather than isolated PUFAs or linoleic acid. Therefore, the biochemical effects observed here cannot be attributed specifically to PUFAs or to LA. Instead, they should be interpreted as effects of corn oil supplementation, with its PUFA content representing one of several components potentially contributing to the observed responses.
Qualitative observations from the SMURF assay suggested differences in intestinal barrier integrity between the dietary groups. In this assay, the presence of Brilliant Blue FCF outside the gastrointestinal tract indicates a loss of intestinal barrier integrity and leakage of intestinal contents into systemic tissues [20]. Flies maintained on the corn oil-supplemented diet appeared to show less extensive dye leakage than those maintained on the standard diet (Figure S2). However, because this observation was not quantitatively assessed, it should be interpreted as supportive qualitative evidence rather than as a demonstration of a protective effect of corn oil on intestinal permeability.
Oxidative stress involves various free radicals and reactive molecules derived from molecular oxygen, nitrogen, and sulfur [41]. When these molecules reduce electron availability, they produce superoxide anions (O2•−), which can react with other cellular components to form more reactive species, such as hydrogen peroxide (H2O2) and hydroxyl radicals (•OH) [42]. Although these reactive species are natural byproducts of mitochondrial respiration, excessive generation can cause significant damage to lipids, proteins, and DNA [43]. Cells counteract this through an antioxidant system that includes enzymes like catalase and molecules such as reduced glutathione (GSH), which help prevent substantial cellular damage [44]. GSH particularly supports catalase by detoxifying residual H2O2 and other peroxides produced during oxidative stress [44].
In Alzheimer’s disease (AD), Aβ disrupts normal mitochondrial function, resulting in alterations in oxidative phosphorylation. This involves a reduction in electron transfer efficiency, which leads to increased production of reactive oxygen species (ROS), primarily at complexes I and III. Additionally, the Aβ peptide not only promotes the generation of ROS at the mitochondrial level but also simultaneously inhibits the removal of ROS [45,46]. Our results showed that mutant flies exposed to AD produced high levels of H2O2, suggesting that oxidative stress was induced. However, supplementation with corn oil was effective in mitigating the damage caused by oxidative stress, as it enhanced the antioxidant capacity of PUFAs or improved mitochondrial parameters [18].
Additionally, we used the pyrogallol and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay to assess the samples’ antioxidant capacity within a superoxide-generating system [47]. Pyrogallol’s self-oxidation produces superoxide, which reduces MTT to formazan through electron transfer by succinate dehydrogenase or mitochondrial complex II. Our findings show that D. melanogaster fed corn oil exhibited less formazan formation in the head region, indicating enhanced mitochondrial complex II activity and stronger local antioxidant defense as described in wild-type flies [18]. However, ingestion of corn oil demonstrated a higher formazan level in the thoraces, suggesting a reduction in succinate dehydrogenase activity. Previous studies have induced oxidative stress in D. melanogaster larvae and adults using H2O2, demonstrating that dietary antioxidant supplements decreased H2O2 levels, boosted antioxidant enzyme activity, and increased survival rates. Higher CAT activity and GSH levels reflected an adaptive response to oxidative stress [48].
The imbalance in cholesterol production contributes to the production and accumulation of β-amyloid peptides (Aβ) and increases β- and γ-secretase activities, favoring the amyloidogenic pathway [49]. Additionally, a reduction in membrane cholesterol displaces the APP protein and secretase activities, favoring the non-amyloidogenic pathway [50,51]. Flies fed corn oil (rich in linoleic acid) showed a reduction in cholesterol in the head, indicating a potential health benefit of the non-amyloidogenic pathway.
Membrane fluidity is affected by cholesterol [52], which can hinder biomolecule transport and enzymatic activity, such as that of acetylcholinesterase (AChE), an enzyme embedded in the membrane responsible for regulating neural signaling [53]. Studies indicate that higher membrane fluidity may affect AChE activity, aiding in the retention of acetylcholine in the synaptic cleft [54,55]. Several studies also demonstrate that PUFAs can enhance membrane fluidity and impact AChE activity, either increasing or decreasing it [55,56,57]. Our results showed increased AChE activity in flies consuming the corn oil-supplemented diet. Changes in redox status, mitochondrial metabolism, and membrane lipid composition may contribute to alterations in AChE activity [58,59]. However, because increased AChE activity may enhance acetylcholine hydrolysis, this response should not be considered inherently beneficial in the context of AD. Rather, the present findings suggest that corn oil supplementation modulates cholinergic metabolism. Finally, our results indicate the preservation of mitochondrial function, accompanied by a reduction in oxidative stress, which may be a cellular adaptation. This suggests that even with mitochondrial impairment, the cells were able to mitigate oxidative stress in flies fed corn oil.
Our work yielded interesting results regarding linoleic acid (LA) supplementation in Drosophila melanogaster genetically modified to model Alzheimer’s disease. However, to further investigate the impact (whether beneficial or detrimental) of LA on disease progression, future complementary experiments could be conducted—such as evaluating the immune response involving the IMD (Immune Deficiency) pathway and NF-κB (Nuclear Factor kappa-light-chain-enhancer of activated B cells). Also, a study demonstrated that high-fat diets can alter the gut microbiota in Drosophila, triggering a systemic inflammatory state that affects the animals [60]. The exacerbation of inflammatory processes, such as the c-Jun N-terminal kinase (JNK) pathway, can accelerate neurodegeneration in mutant Drosophila expressing APP-β42, thereby increasing mortality among the modified animals [61]. JNK, in turn, signals the inflammatory cascade by activating Eiger and its receptor, Wengen; Eiger is a homolog of the mammalian tumor necrosis factor-alpha (TNFα) superfamily and, as in mammals, plays a role in the development and regulation of immunity in Drosophila melanogaster [61,62]. Therefore, evaluating the IMD/NF-κB and JNK inflammatory pathways—combined with the biochemical results obtained in the present study—will provide a more reliable assessment of the impact of LA supplementation in Drosophila models of Alzheimer’s disease, thereby offering a better understanding of how high-fat diets affect neurodegenerative processes.
5. Conclusions
Corn oil supplementation in female flies expressing APP-β42 induced tissue-dependent changes in biochemical, oxidative stress-related, mitochondrial, and neurochemical parameters. The treatment was associated with reduced H2O2 levels, changes in GSH levels, increased citrate synthase activity in head tissue without significant changes in thoracic tissue, and increased AChE activity. These findings indicate that corn oil supplementation modulates redox, mitochondrial, and cholinergic-related parameters in this experimental model. However, the observed changes should not be interpreted as a uniform enhancement of antioxidant defenses or as direct evidence of a neuroprotective effect. Further studies, including quantitative assessment of AD-related phenotypes, are needed to clarify the biological significance of these effects.
Acknowledgments
The authors express their gratitude to the Federal University of Mato Grosso, the Pharmacologic Laboratory of Natural Products, and CAPES. They would also like to thank the anonymous reviewers for their support, demonstrated through their constructive suggestions and corrections on this manuscript.
Abbreviations
The following abbreviations are used in this manuscript:
| APP-β42 | Amyloid precursor protein β42 |
| CS | Citrate synthase |
| AD | Alzheimer’s disease |
| Aβ | β-Amyloid peptide plaques |
| NMDA | N-Methyl-D-aspartate |
| ARIA | Amyloid-related imaging abnormalities |
| BDSC | Bloomington Drosophila Stock Center |
| UAS | Upstream activation sequence |
| GMR-Gal4 | Glass multimer reports Gal4 driver |
| GSH | Reduced glutathione |
| CAT | Catalase |
| H2O2 | Hydrogen peroxide |
| FOX | Ferrous oxidation with xylenol orange |
| DTNB | Dithiobis-2-nitrobenzoic acid |
| AChE | Acetylcholinesterase |
| PUFAs | Polyunsaturated fatty acids |
| LA | Linoleic acid |
| OXLAMs | Oxidized linoleic acid metabolites |
| O2•− | Superoxide anions |
| •OH | Hydroxyl radicals |
| ROS | Reactive oxygen species |
| MTT | 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide |
Supplementary Materials
The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/neurolint18090176/s1, Figure S1: (A) Head of Drosophila melanogaster and the analyzed region in the eye. Confocal microscopy in the heads of (B) GMR-Gal4; UAS-APP-β42 flies fed a standard diet, and (C) GMR-Gal4; UAS-APP-β42 flies fed a standard diet supplemented with corn oil and stained with Congo Red; Figure S2: Permeability of Drosophila melanogaster gut (Smurf test). (A) GMR-Gal4; UAS-APP-β42 flies fed with standard diet; (B) GMR-Gal4; UAS-APP-β42 flies fed with standard diet supplemented with corn oil.
Author Contributions
Conceptualization, J.R.S. and A.O.S.; methodology, J.R.S., M.E.F.O., L.K.P.C. and A.O.S.; software, J.R.S. and A.O.S.; validation, J.R.S., M.E.F.O., L.K.P.C. and A.O.S.; formal analysis, J.R.S., M.E.F.O., L.K.P.C. and A.O.S.; investigation, J.R.S., M.E.F.O., L.K.P.C. and A.O.S.; resources, A.O.S.; data curation, J.R.S., M.E.F.O., L.K.P.C. and A.O.S.; writing—original draft preparation, J.R.S., M.E.F.O., L.K.P.C. and A.O.S.; writing—review and editing, J.R.S., M.E.F.O., L.K.P.C. and A.O.S.; visualization, J.R.S., M.E.F.O., L.K.P.C. and A.O.S.; supervision, A.O.S. and M.J.J.; project administration, A.O.S.; funding acquisition, A.O.S. All authors have read and agreed to the published version of the manuscript.
Data Availability Statement
The data that support the findings of this study are available from the corresponding author upon request.
Conflicts of Interest
The authors declare no conflicts of interest.
Funding Statement
This study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brasil (CAPES)—Finance Code 001.
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
References
- 1.Livingston G., Huntley J., Sommerlad A., Ames D., Ballard C., Bannerjee S., Brayne C., Burns A., Cohen-Mansfield J., Cooper C., et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396:413–446. doi: 10.1016/S0140-6736(20)30367-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Hampel H., Hardy J., Blennow K., Chen C., Perry G., Kim S.H., Villemagne V.L., Aisen P., Vendruscolo M., Iwatsubo T., et al. The Amyloid-β Pathway in Alzheimer’s Disease. Mol. Psychiatry. 2021;26:5481–5503. doi: 10.1038/s41380-021-01249-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Fan L., Mao C., Hu X., Zhang S., Yang Z., Hu Z., Sun H., Fan Y., Dong Y., Yang J., et al. New insights into the pathogenesis of Alzheimer’s disease. Front. Neurol. 2020;10:1312. doi: 10.3389/fneur.2019.01312. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Perluigi M., Di Domenico F., Butterfield D.A. Oxidative damage in neurodegeneration: Roles in the pathogenesis and progression of Alzheimer disease. Physiol. Rev. 2024;104:103–197. doi: 10.1152/physrev.00030.2022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Tahami Monfared A.A., Byrnes M.J., White L.A., Zhang Q. Alzheimer’s Disease: Epidemiology and Clinical Progression. Neurol. Ther. 2022;11:553–569. doi: 10.1007/s40120-022-00338-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Yiannopoulou K.G., Papageorgiou S.G. Current and Future Treatments in Alzheimer Disease: An Update. J. Cent. Nerv. Syst. Dis. 2020;12:117957352090739. doi: 10.1177/1179573520907397. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Zhang J., Zhang Y., Wang J., Xia Y., Zhang J., Chen L. Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies. Signal Transduct. Target. Ther. 2024;9:211. doi: 10.1038/s41392-024-01911-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Chen Z.R., Huang J.B., Yang S.L., Hong F.F. Role of Cholinergic Signaling in Alzheimer’s Disease. Molecules. 2022;27:1816. doi: 10.3390/molecules27061816. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Sereniki A., Vital M.A.B.F. A doença de Alzheimer: Aspectos fisiopatológicos e farmacológicos. Rev. Psiquiatr. Rio Gd. Sul. 2008;30 doi: 10.1590/S0101-81082008000200002. [DOI] [Google Scholar]
- 10.Cummings J., Osse A.M.L., Cammann D., Powell J., Chen J. Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease. BioDrugs. 2024;38:5–22. doi: 10.1007/s40259-023-00633-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Ruangritchankul S., Chantharit P., Srisuma S., Gray L.C. Adverse Drug Reactions of Acetylcholinesterase Inhibitors in Older People Living with Dementia: A Comprehensive Literature Review. Ther. Clin. Risk Manag. 2021;17:927–949. doi: 10.2147/TCRM.S323387. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Doran S.J., Sawyer R.P. Risk factors in developing amyloid related imaging abnormalities (ARIA) and clinical implications. Front. Neurosci. 2024;18:1326784. doi: 10.3389/fnins.2024.1326784. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Essa M.M., Bishir M., Bhat A., Chidambaram S.B., Al-Balushi B., Hamdan H., Govindarajan N., Freidland R.P., Qoronfleh M.W. Functional foods and their impact on health. J. Food Sci. Technol. 2023;60:820–834. doi: 10.1007/s13197-021-05193-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Hajzer Z.E., Alibrahem W., Kharrat Helu N., Oláh C., Prokisch J. Functional Foods in Clinical Trials and Future Research Directions. Foods. 2025;14:2675. doi: 10.3390/foods14152675. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Maki K.C., Hasse W., Dicklin M.R., Bell M., Buggia M.A., Cassens M.E., Eren F. Corn Oil Lowers Plasma Cholesterol Compared with Coconut Oil in Adults with Above-Desirable Levels of Cholesterol in a Randomized Crossover Trial. J. Nutr. 2018;148:1556–1563. doi: 10.1093/jn/nxy156. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Sánchez-Nuño Y.A., Zermeño-Ruiz M., Vázquez-Paulino O.D., Nuño K., Villarruel-López A. Bioactive compounds from pigmented corn (Zea mays L.) and their effect on health. Biomolecules. 2024;14:338. doi: 10.3390/biom14030338. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Alencar L.P., Costa L.L., Lisboa D.R., Silva J.R., Santos S.F., Pereira M.P., Yamaguchi K.K.L., Souza A.O. Piranhea trifoliata extracts ameliorate muscular decline in Drosophila melanogaster exposed to Paraquat. Arch. Insect Biochem. Physiol. 2023;112:e21994. doi: 10.1002/arch.21994. [DOI] [PubMed] [Google Scholar]
- 18.Ramalho D.L., Silva J.R., Brugnera M.F., Moura S., Souza A.O. Neurotoxic and behavioral deficit in Drosophila melanogaster exposed to photocatalytic products of Paraquat. Neurotoxicology. 2024;104:11–19. doi: 10.1016/j.neuro.2024.06.012. [DOI] [PubMed] [Google Scholar]
- 19.Silva J.R., Alves T.H.O., Santos E.B.S., Lima M.M., Spegiorim G.C., Couto-Lima C.A., Alberici L.C., Jacinto M.J., Souza A.O. Corn Oil Supplementation Enhances Locomotor Performance and Mitochondrial Function in Drosophila melanogaster. Appl. Sci. 2025;15:7607. doi: 10.3390/app15137607. [DOI] [Google Scholar]
- 20.Rera M., Clark R.I., Walker D.W. Intestinal barrier dysfunction links metabolic and inflammatory markers of aging to death in Drosophila. Proc. Natl. Acad. Sci. USA. 2012;109:21528–21533. doi: 10.1073/pnas.1215849110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Hissin P.J., Hilf R. A Fluorometric Method for Determination of Oxidized and Reduced Glutathione in Tissues. Anal. Biochem. 1976;74:214–226. doi: 10.1016/0003-2697(76)90326-2. [DOI] [PubMed] [Google Scholar]
- 22.Ramalho D.L., Silva J.R., Santos M.E.M.M., Soares M.E.S., Jesus A.A.T., Alves T.H.O., Brugnera M.F., Moura S., Souza A.O. The neurotoxicity of Paraquat and its degradation products on Drosophila melanogaster. Sci. Rep. 2025;15:16447. doi: 10.1038/s41598-025-86413-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Aebi H. [13] Catalase in vitro. Methods Enzymol. 1984;105:121–126. doi: 10.1016/S0076-6879(84)05016-3. [DOI] [PubMed] [Google Scholar]
- 24.Rao S.V., Muralidhara, Yenisetti S.C., Rajini P.S. Evidence of neuroprotective effects of saffron and crocin in a Drosophila model of parkinsonism. Neurotoxicology. 2016;52:230–242. doi: 10.1016/j.neuro.2015.12.010. [DOI] [PubMed] [Google Scholar]
- 25.Souza A.O., Couto-Lima C.A., Catalão C.H.R., Santos-Júnior N.N., Santos J.F., Rocha M.J.A., Alberici L.C. Neuroprotective action of Eicosapentaenoic (EPA) and Docosahexaenoic (DHA) acids on Paraquat intoxication in Drosophila melanogaster. Neurotoxicology. 2019;70:154–160. doi: 10.1016/j.neuro.2018.11.013. [DOI] [PubMed] [Google Scholar]
- 26.Srere P.A. [1] Citrate synthase: [EC 4.1.3.7. Citrate oxaloacetate-lyase (CoA-acetylating)] Methods Enzymol. 1969;13:3–11. doi: 10.1016/0076-6879(69)13005-0. [DOI] [Google Scholar]
- 27.Marklund S., Marklund G. Involvement of the Superoxide Anion Radical in the Autoxidation of Pyrogallol and a Convenient Assay for Superoxide Dismutase. Eur. J. Biochem. 1974;47:469–474. doi: 10.1111/j.1432-1033.1974.tb03714.x. [DOI] [PubMed] [Google Scholar]
- 28.Ellman G.L., Courtney K.D., Andres V., Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961;7:88–95. doi: 10.1016/0006-2952(61)90145-9. [DOI] [PubMed] [Google Scholar]
- 29.Souza A.O., Couto-Lima C.A., Machado M.C.R., Espreafico E.M., Ramos R.G.P., Alberici L.C. Protective action of Omega-3 on paraquat intoxication in Drosophila melanogaster. J. Toxicol. Environ. Health-Part A. 2017;80:1050–1063. doi: 10.1080/15287394.2017.1357345. [DOI] [PubMed] [Google Scholar]
- 30.Bradford M.M. A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding. Anal. Biochem. 1976;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
- 31.Mititelu M., Lupuliasa D., Neacsu S.M., Olteanu G., Busnatu S.S., Mihai A., Popovici V., Maru N., Boroghina S.C., Mihai S., et al. Polyunsaturated Fatty Acids and Human Health: A Key to Modern Nutritional Balance in Association with Polyphenolic Compounds from Food Sources. Foods. 2024;14:46. doi: 10.3390/foods14010046. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Mozaffarian D., Wu J.H.Y. Omega-3 Fatty Acids and Cardiovascular Disease. J. Am. Coll. Cardiol. 2011;58:2047–2067. doi: 10.1016/j.jacc.2011.06.063. [DOI] [PubMed] [Google Scholar]
- 33.Abdelhamid A.S., Brown T.J., Brainard J.S., Biswas P., Thorpe G.C., Moore H.J., Deane K.H., AlAbdulghafoor F.K., Summerbell C.D., Worthington H.V., et al. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst. Rev. 2018;7:CD003177. doi: 10.1002/14651858.CD003177.pub3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Silva J.R., Prescillio I.C., Yamaguchi K.K.L., Silva E.J.A., Souza A.O. Beneficial effects of Docosahexaenoic acid consumption on brain health: A mini-review. J. Food Bioact. 2024;26:1–6. doi: 10.31665/JFB.2024.18375. [DOI] [Google Scholar]
- 35.Innes J.K., Calder P.C. Omega-6 fatty acids and inflammation. Prostaglandins Leukot. Essent. Fat. Acids. 2018;132:41–48. doi: 10.1016/j.plefa.2018.03.004. [DOI] [PubMed] [Google Scholar]
- 36.Kim O.Y., Song J. Important roles of linoleic acid and α-linolenic acid in regulating cognitive impairment and neuropsychiatric issues in metabolic-related dementia. Life Sci. 2024;337:122356. doi: 10.1016/j.lfs.2023.122356. [DOI] [PubMed] [Google Scholar]
- 37.Mohammadi S., Keshteli A.H., Saneei P., Afshar H., Esmailzadeh A., Adibi P. The Relationship Between Linoleic Acid Intake and Psychological Disorders in Adults. Front. Nutr. 2022;9:841282. doi: 10.3389/fnut.2022.841282. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Mercola J., D’Adamo C.R. Linoleic Acid: A Narrative Review of the Effects of Increased Intake in the Standard American Diet and Associations with Chronic Disease. Nutrients. 2023;15:3129. doi: 10.3390/nu15143129. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Carvalho M., Sampaio J.L., Palm W., Brankatschk M., Eaton S., Shevchenko A. Effects of diet and development on the Drosophila lipidome. Mol. Syst. Biol. 2012;8:600. doi: 10.1038/msb.2012.29. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Hunter-Manseau F., Cormier S.B., Strang R., Pichaud N. Fasting as a precursor to high-fat diet enhances mitochondrial resilience in Drosophila melanogaster. Insect Sci. 2024;31:1770–1788. doi: 10.1111/1744-7917.13355. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Garcia-Llorens G., Ouardi M.E., Valls-Belles V. Oxidative stress fundamentals: Unraveling the pathophysiological role of redox imbalance in non-communicable diseases. Appl. Sci. 2025;15:10191. doi: 10.3390/app151810191. [DOI] [Google Scholar]
- 42.Andrés C.M.C., Lastra J.M.P., Juan C.A., Plou F.J., Pérez-Lebeña E. Superoxide Anion Chemistry—Its Role at the Core of the Innate Immunity. Int. J. Mol. Sci. 2023;24:1841. doi: 10.3390/ijms24031841. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Juan C.A., Lastra J.M.P., Plou F.J., Pérez-Lebeña E. The Chemistry of Reactive Oxygen Species (ROS) Revisited: Outlining Their Role in Biological Macromolecules (DNA, Lipids and Proteins) and Induced Pathologies. Int. J. Mol. Sci. 2021;22:4642. doi: 10.3390/ijms22094642. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Jomova K., Alomar S.Y., Alwasel S.H., Nepovimova E., Kuca K., Valko M. Several lines of antioxidant defense against oxidative stress: Antioxidant enzymes, nanomaterials with multiple enzyme-mimicking activities, and low-molecular-weight antioxidants. Arch. Toxicol. 2024;98:1323–1367. doi: 10.1007/s00204-024-03696-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Tamagno E., Guglielmotto M., Vasciaveo V., Tabaton M. Oxidative Stress and Beta Amyloid in Alzheimer’s Disease. Which Comes First: The Chicken or the Egg? Antioxidants. 2021;10:1479. doi: 10.3390/antiox10091479. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Huang W.J., Zhang X., Chen W.W. Role of oxidative stress in Alzheimer’s disease. Biomed. Rep. 2016;4:519–522. doi: 10.3892/br.2016.630. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Xu C., Liu S., Liu Z., Song F., Liu S. Superoxide generated by pyrogallol reduces highly water-soluble tetrazolium salt to produce a soluble formazan: A simple assay for measuring superoxide anion radical scavenging activities of biological and abiological samples. Anal. Chim. Acta. 2013;793:53–60. doi: 10.1016/j.aca.2013.07.027. [DOI] [PubMed] [Google Scholar]
- 48.Johnmark N., Kinyi H.W. Amaranth leaf extract protects against hydrogen peroxide induced oxidative stress in Drosophila melanogaster. BMC Res. Notes. 2021;14:188. doi: 10.1186/s13104-021-05603-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Rudajev V., Novotny J. Cholesterol-dependent amyloid β production: Space for multifarious interactions between amyloid precursor protein, secretases, and cholesterol. Cell Biosci. 2023;13:171. doi: 10.1186/s13578-023-01127-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Puglielli L., Tanzi R.E., Kovacs D.M. Alzheimer’s disease: The cholesterol connection. Nat. Neurosci. 2023;6:345–351. doi: 10.1038/nn0403-345. [DOI] [PubMed] [Google Scholar]
- 51.Pantelopulos G.A., Abraham C.B., Straub J.E. Cholesterol and Lipid Rafts in the Biogenesis of Amyloid-β Protein and Alzheimer’s Disease. Annu. Rev. Biophys. 2024;53:455–486. doi: 10.1146/annurev-biophys-062823-023436. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Fernández-Pérez E.J., Sepúlveda F.J., Peters C., Bascunan D., Riffo-Lepe N.O., González-Sanmiguel J., Sánchez S.A., Peoples R.W., Vicente B., Aguayo L.G. Effect of Cholesterol on Membrane Fluidity and Association of Aβ Oligomers and Subsequent Neuronal Damage: A Double-Edged Sword. Front. Aging Neurosci. 2018;10:226. doi: 10.3389/fnagi.2018.00226. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Shin K.C., Ali Moussa H.Y., Park Y. Cholesterol imbalance and neurotransmission defects in neurodegeneration. Exp. Mol. Med. 2024;56:1685–1690. doi: 10.1038/s12276-024-01273-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Hashimoto M., Hossain S., Shimada T., Shido O. Docosahexaenoic acid-induced protective effect against impaired learning in amyloid β-infused rats is associated with increased synaptosomal membrane fluidity. Clin. Exp. Pharmacol. Physiol. 2006;33:934–939. doi: 10.1111/j.1440-1681.2006.04467.x. [DOI] [PubMed] [Google Scholar]
- 55.Willis L.M., Shukitt-Hale B., Joseph J.A. Dietary polyunsaturated fatty acids improve cholinergic transmission in the aged brain. Genes Nutr. 2009;4:309–314. doi: 10.1007/s12263-009-0141-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Zhu D., Bungart B.L., Yang X., Zhumadilov Z., Lee J.C.M., Askarova S. Role of membrane biophysics in Alzheimer’s related cell pathways. Front. Neurosci. 2015;9:186. doi: 10.3389/fnins.2015.00186. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Jacobs M.L., Faizi H.A., Peruzzi J.A., Vlahovska P.M., Kamat N.P. EPA and DHA differentially modulate membrane elasticity in the presence of cholesterol. Biophys. J. 2021;120:2317–2329. doi: 10.1016/j.bpj.2021.04.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Sternfeld M., Shoham S., Klein O., Flores-Flores O., Evron T., Idelson G.H., Kitsberg D., Patrick J.W., Soreq H. Excess “read-through” acetylcholinesterase attenuates but the “synaptic” variant intensifies neurodeterioration correlates. Proc. Natl. Acad. Sci. USA. 2000;97:8647–8652. doi: 10.1073/pnas.140004597. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Horman T., Fernandes M.F., Tache M.C., Hucik B., Mutch D.M., Leri F. Dietary n-6/n-3 Ratio Influences Brain Fatty Acid Composition in Adult Rats. Nutrients. 2020;12:1847. doi: 10.3390/nu12061847. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Wang J., Gu J., Yi J., Li J., Li W., Zhai Z. High-fat diets induce inflammatory IMD/NFκB signaling via gut microbiota remodeling in Drosophila. Front. Cell Infect. Microbiol. 2024;14:1347716. doi: 10.3389/fcimb.2024.1347716. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Tare M., Modi R.M., Nainaparampil J.J., Puli O.R., Bedi S., Fernandez-Funez P., Kango-Singh M., Singh A. Activation of JNK Signaling Mediates Amyloid-ß-Dependent Cell Death. PLoS ONE. 2011;6:e24361. doi: 10.1371/journal.pone.0024361. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Bertinelli M., Paesen G.C., Grimes J.M., Renner M. High-resolution crystal structure of arthropod Eiger TNF suggests a mode of receptor engagement and altered surface charge within endosomes. Commun. Biol. 2019;2:293. doi: 10.1038/s42003-019-0541-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The data that support the findings of this study are available from the corresponding author upon request.
